These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18324772)

  • 1. Dietary phosphatidylinositol prevents the development of nonalcoholic fatty liver disease in Zucker (fa/fa) rats.
    Shirouchi B; Nagao K; Inoue N; Furuya K; Koga S; Matsumoto H; Yanagita T
    J Agric Food Chem; 2008 Apr; 56(7):2375-9. PubMed ID: 18324772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term feeding of a synthetic diet rich in disaccharides induces hepatic fibrosis in nonalcoholic fatty liver disease in Zucker rats.
    Fukunishi S; Nishio H; Fukuda A; Takeshita A; Hanafusa T; Higuchi K; Suzuki K
    Int J Mol Med; 2010 Feb; 25(2):187-93. PubMed ID: 20043126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional lipids and the prevention of the metabolic syndrome.
    Yanagita T; Nagao K
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():189-91. PubMed ID: 18296334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dietary phosphatidylinositol on cholesterol metabolism in Zucker (fa/fa) rats.
    Shirouchi B; Nagao K; Furuya K; Inoue N; Inafuku M; Nasu M; Otsubo K; Koga S; Matsumoto H; Yanagita T
    J Oleo Sci; 2009; 58(3):111-5. PubMed ID: 19202308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary conjugated linoleic acid alleviates nonalcoholic fatty liver disease in Zucker (fa/fa) rats.
    Nagao K; Inoue N; Wang YM; Shirouchi B; Yanagita T
    J Nutr; 2005 Jan; 135(1):9-13. PubMed ID: 15623825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mukitake mushroom (Panellus serotinus) alleviates nonalcoholic fatty liver disease through the suppression of monocyte chemoattractant protein 1 production in db/db mice.
    Nagao K; Inoue N; Inafuku M; Shirouchi B; Morooka T; Nomura S; Nagamori N; Yanagita T
    J Nutr Biochem; 2010 May; 21(5):418-23. PubMed ID: 19423319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nateglinide prevents fatty liver through up-regulation of lipid oxidation pathway in Goto-Kakizaki rats on a high-fat diet.
    Mine T; Miura K; Kajioka T; Kitahara Y
    Metabolism; 2008 Jan; 57(1):140-8. PubMed ID: 18078871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A casein diet added isoflavone-enriched soy protein favorably affects biomarkers of steatohepatitis in obese Zucker rats.
    Gudbrandsen OA; Wergedahl H; Berge RK
    Nutrition; 2009 May; 25(5):574-80. PubMed ID: 19101115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats.
    Gary-Bobo M; Elachouri G; Gallas JF; Janiak P; Marini P; Ravinet-Trillou C; Chabbert M; Cruccioli N; Pfersdorff C; Roque C; Arnone M; Croci T; Soubrié P; Oury-Donat F; Maffrand JP; Scatton B; Lacheretz F; Le Fur G; Herbert JM; Bensaid M
    Hepatology; 2007 Jul; 46(1):122-9. PubMed ID: 17526015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary single cell protein reduces fatty liver in obese Zucker rats.
    Gudbrandsen OA; Wergedahl H; Liaset B; Espe M; Mørk S; Berge RK
    Br J Nutr; 2008 Oct; 100(4):776-85. PubMed ID: 18346305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic hepatic steatosis in Zucker diabetic rats: spontaneous evolution and effects of metformin and fenofibrate.
    Forcheron F; Abdallah P; Basset A; del Carmine P; Haffar G; Beylot M
    Obesity (Silver Spring); 2009 Jul; 17(7):1381-9. PubMed ID: 19553925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dietary omega 3 phosphatidylcholine on obesity-related disorders in obese Otsuka Long-Evans Tokushima fatty rats.
    Shirouchi B; Nagao K; Inoue N; Ohkubo T; Hibino H; Yanagita T
    J Agric Food Chem; 2007 Aug; 55(17):7170-6. PubMed ID: 17661494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grape-seed procyanidins prevent low-grade inflammation by modulating cytokine expression in rats fed a high-fat diet.
    Terra X; Montagut G; Bustos M; Llopiz N; Ardèvol A; Bladé C; Fernández-Larrea J; Pujadas G; Salvadó J; Arola L; Blay M
    J Nutr Biochem; 2009 Mar; 20(3):210-8. PubMed ID: 18602813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA; Hadziyannis SJ
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of hepatic peroxisome proliferator-activated receptor alpha expression but not adiponectin by dietary protein in finishing pigs.
    Weber TE; Kerr BJ; Spurlock ME
    J Anim Physiol Anim Nutr (Berl); 2008 Oct; 92(5):569-77. PubMed ID: 19012601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats.
    Rivera L; Morón R; Sánchez M; Zarzuelo A; Galisteo M
    Obesity (Silver Spring); 2008 Sep; 16(9):2081-7. PubMed ID: 18551111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H; Daram SR
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome.
    Targher G; Chonchol M; Miele L; Zoppini G; Pichiri I; Muggeo M
    Semin Thromb Hemost; 2009 Apr; 35(3):277-87. PubMed ID: 19452403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
    Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
    Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.